Company / Current Liabilities per Share
Edgewise Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.27
FY2025
5-year range
$0.26 / $0.31
FY2021-FY2025
Trend
+3.0%
vs FY2024
Sector context
#182 of 210
Health Care
What the data says
Edgewise Therapeutics, Inc.'s current liabilities per share of $0.27 is lower than 87% of companies in the Health Care sector (FY2025). Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $0.27.
Based on SEC 10-K filings.
0.27 in FY2025 with a 5-year CAGR of -46.2%.
Remained stable around $0.27 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -4.9%
- 5-Year CAGR
- -46.2%
- 10-Year CAGR
- -
Sector benchmark
-98.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 3.0% year-over-year.
- Ranks #182 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | +3.0% |
| FY2024 | $0.26 | -1.9% |
| FY2023 | $0.26 | -15.0% |
| FY2022 | $0.31 | +10.4% |
| FY2021 | $0.28 | -95.2% |
| FY2020 | $5.88 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026